Exelixis (EXEL) Cash & Current Investments (2010 - 2026)
Exelixis (EXEL) posted Cash & Current Investments of $839.39 million for Q2 2027, up 6.1% from $791.1 million a year earlier and up 8.0% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2026, Exelixis' Cash & Current Investments came in at $1.06 billion, down 4.7% from FY2025.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of -6.3% (FY2021 to FY2026).
- In prior years, Exelixis' Cash & Current Investments was $1.11 billion in FY2025, $995.3 million in FY2023 (-23.9%) and $1.31 billion in FY2022 (-10.8%).
- Quarterly Cash & Current Investments has run from a low of $777.21 million in Q1 2027 to a high of $1.19 billion in Q3 2025 over five years.
- On a year-over-year basis, Cash & Current Investments increased in two of the last six quarters, with an average decline of 9.0%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $777.21 million (Q1 2027), $1.06 billion (Q4 2026) and $988.54 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Exelixis | 14.53 Bn | 10.87 Bn | 608.03 Mn | 839.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 839.39 Mn |
| Apr 3, 2026 | 777.21 Mn |
| Jan 2, 2026 | 1.06 Bn |
| Oct 3, 2025 | 988.54 Mn |
| Jul 4, 2025 | 791.10 Mn |
| Apr 4, 2025 | 1.03 Bn |
| Jan 3, 2025 | 1.11 Bn |
| Sep 27, 2024 | 1.19 Bn |
| Jun 28, 2024 | 1.00 Bn |
| Mar 29, 2024 | 963.26 Mn |
| Dec 29, 2023 | 995.30 Mn |
| Sep 29, 2023 | 1.10 Bn |
| Jun 30, 2023 | 1.27 Bn |
| Mar 31, 2023 | 1.31 Bn |
| Dec 30, 2022 | 1.31 Bn |
| Sep 30, 2022 | 1.55 Bn |
| Jul 1, 2022 | 1.53 Bn |
| Apr 1, 2022 | 1.57 Bn |
| Dec 31, 2021 | 1.47 Bn |
| Oct 1, 2021 | 1.40 Bn |
API Access
Exelixis Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();